Brandywine Global Investment Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-37,910
Closed -$1.04M 662
2025
Q3
$1.04M Buy
+37,910
New +$1.17M 0.01% 545
2014
Q4
Sell
-121,460
Closed -$4.47M 1034
2014
Q3
$4.47M Buy
121,460
+14,820
+14% +$535K 0.03% 434
2014
Q2
$4.17M Sell
106,640
-10,000
-9% -$371K 0.03% 433
2014
Q1
$4.39M Buy
116,640
+1,260
+1% +$44K 0.04% 411
2013
Q4
$4.36M Buy
115,380
+5,960
+5% +$228K 0.04% 392
2013
Q3
$4.75M Buy
109,420
+6,000
+6% +$241K 0.05% 364
2013
Q2
$3.74M Buy
+103,420
New +$3.14M 0.04% 399

Other funds holding USNA

Brandywine Global Investment Management's USNA Position: Q4 2025 in Review

Brandywine Global Investment Management sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 37,910 shares — an estimated $1.04M sold.

Brandywine Global Investment Management first reported a position in USNA in Q2 2013 and held it in 7 quarters. The position peaked at $4.75M in Q3 2013. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

  • Brandywine Global Investment Management reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
  • Brandywine Global Investment Management sold 37,910 Usana Health Sciences shares in Q4 2025, an estimated $1.04M.
  • Brandywine Global Investment Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 7 quarters.
  • Brandywine Global Investment Management's Usana Health Sciences position peaked at $4.75M in Q3 2013.
  • 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.